Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 60-65 , October 2010

The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes

  • Yao Ma

      Affiliations

    • Obstetrics & Gynecology Hospital, Fudan University, China
    • ,
  • Yan Cheng

      Affiliations

    • Obstetrics & Gynecology Hospital, Fudan University, China
    • ,
  • Jue Wang

      Affiliations

    • Obstetrics & Gynecology Hospital, Fudan University, China
    • ,
  • Haidong Cheng

      Affiliations

    • Obstetrics & Gynecology Hospital, Fudan University, China
    • ,
  • Shufeng Zhou

      Affiliations

    • School of Health Sciences, RMIT University, Bundoora, Victoria 3083, Australia
    • ,
  • Xiaotian Li

      Affiliations

    • Obstetrics & Gynecology Hospital, Fudan University, China
    • Institute of Biomedical Sciences, Fudan University, China
    • Corresponding Author InformationCorresponding author at: Obstetrics and Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai 200011, China. Tel.: +86 21 6345 5050; fax: +86 21 6345 5090.

Received 26 March 2010 ,Revised 21 May 2010 ,Accepted 8 June 2010.

References 

  1. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67:341–347
  2. Briana DD, Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16:921–937
  3. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30(Suppl. 2):S120–S126
  4. Chen J, Tan B, Karteris E, Zervou S, Digby J, Hillhouse EW, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49:1292–1302
  5. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol. 1994;14:1431–1437
  6. Preiss J, Handler P. Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem. 1957;225:759–770
  7. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426–430
  8. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol. 2007;23:164–170
  9. Filippatos TD, Derdemezis CS, Gazi IF, Lagos K, Kiortsis DN, Tselepis AD, et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest. 2008;38:71–72
  10. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004;113:1318–1327
  11. Morgan SA, Bringolf JB, Seidel ER. Visfatin expression is elevated in normal human pregnancy. Peptides. 2008;29:1382–1389
  12. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol. 2002;187:1051–1058
  13. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51:2207–2213
  14. Gestational diabetes mellitus. Diabetes Care. 2004;27(Suppl. 1):S88–S90
  15. Patel N, Alsat E, Igout A, Baron F, Hennen G, Porquet D, et al. Glucose inhibits human placental GH secretion, in vitro. J Clin Endocrinol Metab. 1995;80:1743–1746
  16. Lewandowski KC, Stojanovic N, Press M, Tuck SM, Szosland K, Bienkiewicz M, et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia. 2007;50:1033–1037
  17. Krzyzanowska K, Krugluger W, Mittermayer F, Rahman R, Haider D, Shnawa N, et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond). 2006;110:605–609
  18. Telejko B, Kuzmicki M, Zonenberg A, Szamatowicz J, Wawrusiewicz-Kurylonek N, Nikolajuk A, et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract. 2009;84:68–75
  19. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007;6:363–375
  20. Song HK, Lee MH, Kim BK, Park YG, Ko GJ, Kang YS, et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol. 2008;295:F1485–F1494
  21. Ognjanovic S, Bao S, Yamamoto SY, Garibay-Tupas J, Samal B, Bryant-Greenwood GD. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol. 2001;26:107–117
  22. Haider S, Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta. 2009;30:111–123
  23. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139:327–335

PII: S0168-8227(10)00311-6

doi: 10.1016/j.diabres.2010.06.010

Diabetes Research and Clinical Practice
Volume 90, Issue 1 , Pages 60-65 , October 2010

Article Tools

* Image Usage & Resolution